Increased intraocular pressure during treatment for chronic uveitis
- PMID: 9143886
- DOI: 10.1007/BF00941759
Increased intraocular pressure during treatment for chronic uveitis
Abstract
Objectives: (1) To prospectively evaluate the incidence of increased intraocular pressure (IOP) in patients suffering from chronic uveitis. (2) To identify the main factors responsible for an increase in the IOP among these patients.
Methods: Two hundred and one patients suffering from chronic uveitis were included. Enrolled patients had an initial IOP of 8-18 mmHg. The patients were treated and clinically monitored during a period of 4 years. The IOP was measured at each visit and its changes followed prospectively. All patients were followed up for at least 12 months after enrollment.
Results: Twenty-four (12%) of the 201 patients had IOP higher than 24 mmHg at two or more consecutive visits. Of these 24 patients, 19 suffered from bilateral uveitis and 5 had unilateral disease. Four of the 19 patients with bilateral uveitis developed a constant IOP higher than 24 mmHg in both eyes, while in 15 patients an IOP higher than 24 mmHg persisted only in one eye. A close association between the increased IOP and the use of corticosteroids was found in 18 of the 24 cases (75%). This association was ascertained in 16 of these patients by the decrease in IOP levels on discontinuation of the corticosteroid regimen and the renewed increase IOP was due to pupillary block in three cases (12.5%), to iris and angle neovascularization in two (8.3%), and to the inflammatory process per se in one case only (4.2%).
Conclusions: This study demonstrates that a persistent elevation of the IOP in patients suffering from chronic uveitis is, in the majority of cases, associated with the use of corticosteroids.
Similar articles
-
Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.Am J Ophthalmol. 2009 Aug;148(2):207-213.e1. doi: 10.1016/j.ajo.2009.02.032. Epub 2009 Apr 29. Am J Ophthalmol. 2009. PMID: 19403113
-
Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.JAMA Ophthalmol. 2015 May;133(5):568-73. doi: 10.1001/jamaophthalmol.2015.51. JAMA Ophthalmol. 2015. PMID: 25719937 Clinical Trial.
-
Ocular-hypertensive response to topical steroids in children.Ophthalmology. 1997 Dec;104(12):2112-6. doi: 10.1016/s0161-6420(97)30052-9. Ophthalmology. 1997. PMID: 9400772 Clinical Trial.
-
Corticosteroid therapy of eye disease. Fifty years later.Arch Ophthalmol. 1996 Aug;114(8):1000-1. doi: 10.1001/archopht.1996.01100140208016. Arch Ophthalmol. 1996. PMID: 8694704 Review. No abstract available.
-
Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.Adv Ther. 2016 Apr;33(4):532-52. doi: 10.1007/s12325-016-0315-8. Epub 2016 Mar 17. Adv Ther. 2016. PMID: 26984315 Free PMC article. Review.
Cited by
-
Difference in glaucoma progression between the first and second eye after consecutive bilateral glaucoma surgery in patients with bilateral uveitic glaucoma.Graefes Arch Clin Exp Ophthalmol. 2016 Dec;254(12):2439-2448. doi: 10.1007/s00417-016-3460-5. Epub 2016 Aug 6. Graefes Arch Clin Exp Ophthalmol. 2016. PMID: 27495303 Free PMC article.
-
Long-term stability of uveitis with faint anterior chamber flare treated with once-daily topical ophthalmic betamethasone.Inflammation. 2014 Apr;37(2):417-25. doi: 10.1007/s10753-013-9754-4. Inflammation. 2014. PMID: 24114448
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical